DCF — ENCOMPASS HEALTH REHABILITATION HOSP
Enterprise Value: $42.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$42.1M
Enterprise Value
$11.5M
PV of Cash Flows
$30.6M
PV of Terminal Value
$49.3M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $36.8M | $5.0M | 14.0% | $2.4M | $2.2M |
| Year 2 | $37.9M | $5.6M | 15.0% | $2.8M | $2.3M |
| Year 3 | $39.0M | $6.1M | 16.0% | $3.2M | $2.4M |
| Year 4 | $40.2M | $6.5M | 16.0% | $3.4M | $2.3M |
| Year 5 | $41.4M | $6.8M | 16.0% | $3.6M | $2.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $42.1M. Terminal value accounts for 73% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$35.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.13185733457790658
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5